Epigenetics of Homocystinuria, Hydrogen Sulfide, and Circadian Clock Ablation in Cardiovascular-Renal Disease

被引:0
|
作者
Tyagi, Suresh C. [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA
关键词
folate 1-carbon metabolism; heart failure; ATP-citrate lyase; gene writer; gene eraser and editor; Piezo; interoception; HFpEF; HFrEF; AKI; CKD; K-ATP CHANNEL; TRIGGERS MITOCHONDRIA DEGRADATION; ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE BETA-SYNTHASE; BLOOD-PRESSURE VARIATION; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; OXIDATIVE STRESS; HEART-FAILURE; DIASTOLIC DYSFUNCTION;
D O I
10.3390/cimb46120824
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Morning-time heart attacks are associated with an ablation in the sleep-time dip in blood pressure, the mechanism of which is unknown. The epigenetic changes are the hallmark of sleep and circadian clock disruption and homocystinuria (HHcy). The homocystinuria causes ablation in the dip in blood pressure during sleep. Interestingly, HHcy is generated during the epigenetic gene turning off and turning on (i.e., imprinting) by methylation of the DNA promoter. The mitochondrial sulfur metabolism by 3-mercaptopyruvate sulfur transferase (3MST), ATP citrate lyase (ACYL), and epigenetic rhythmic methylation are regulated by folate 1-carbon metabolism (FOCM), i.e., the methionine (M)-SAM-SAH-Hcy, adenosine, and uric acid cycle. Epigenetic gene writer (DNMT), gene eraser (TET/FTO), and editor de-aminase (ADAR) regulate the rhythmic, i.e., reversible methylation/demethylation of H3K4, H3K9, H4K20, m6A, and m5C. The mitochondrial ATP citrate cycle and creatine kinase (CK) regulate chromatin transcription, maturation, and accessibility as well as muscle function. The transcription is regulated by methylation. The maturation and accessibility are controlled by acetylation. However, it is unclear whether a high fat dysbiotic diet (HFD) causes dysrhythmic expression of the gene writer, eraser, and editor, creating hyperuricemia and cardiac and renal dysfunction. We hypothesized that an HFD increases the gene writer (DNMT1) and editor (ADAR), decreases the eraser (TET/FTO), and increases uric acid to cause chronic diseases. This increases the levels of H3K4, H3K9, H4K20, m6A, and m5C. Interestingly, the DNMT1KO mitigates. Further, the DNMT1KO and ADAR inhibition attenuate HFD-induced NGAL/FGF23/TMPRSS2/MMP2, 9, 13, and uric acid levels and improve cardiac and renal remodeling. Although the novel role of nerve endings by the Piezo channels (i.e., the combination of ENaC, VDAC, TRPV, K+, and Mg2+ channels) in the interoception is suggested, interestingly, we and others have shown mechanisms independent of the nerve, by interoception, such as the cargo of the exosome in denervation models of heart failure. If proper and appropriate levels of these enzymes are available to covert homocysteine to hydrogen sulfide (H2S) during homocystinuria, then the H2S can potentially serve as a newer form of treatment for morning heart attacks and renal sulfur transsulfuration transport diseases.
引用
收藏
页码:13783 / 13797
页数:15
相关论文
共 50 条
  • [21] The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease
    Ravarotto, Verdiana
    Bertoldi, Giovanni
    Innico, Georgie
    Gobbi, Laura
    Calo, Lorenzo A.
    ANTIOXIDANTS, 2021, 10 (07)
  • [22] Novel hydrogen sulfide therapeutics for cardiovascular disease
    Lefer, David J.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2015, 47 : S9 - S9
  • [23] The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease
    Wen, Ya-Dan
    Wang, Hong
    Zhu, Yi-Zhun
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [24] The Renal Circadian Clock Is Disrupted in Autosomal Polycystic Kidney Disease
    Jamadar, Abeda
    Douma, Lauren G.
    Gumz, Michelle L.
    Rao, Reena
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 404 - 404
  • [25] Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
    Ravarotto, Verdiana
    Carraro, Gianni
    Pagnin, Elisa
    Bertoldi, Giovanni
    Simioni, Francesca
    Maiolino, Giuseppe
    Martinato, Matteo
    Landini, Linda
    Davis, Paul A.
    Calo, Lorenzo A.
    PLOS ONE, 2018, 13 (09):
  • [26] Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease
    Li, Zhen
    Polhemus, David J.
    Lefer, David J.
    CIRCULATION RESEARCH, 2018, 123 (05) : 590 - 600
  • [27] Discontinuation of Renin Angiotensin System Inhibitor and Cardiovascular-Renal Events in Advanced Diabetic Kidney Disease
    Shi, Mai
    Yang, Aimin
    Lau, Eric S. H.
    Wu, Hongjiang
    Zhang, Xinge
    Fan, Baoqi
    Kong, Alice P.
    Luk, Andrea
    Ma, Ronald C.
    Chan, Juliana C.
    Chow, Elaine
    DIABETES, 2022, 71
  • [28] Circadian clock control of body temperature and cardiovascular function: implications for health and disease
    Scheer, F. A. J. L.
    JOURNAL OF SLEEP RESEARCH, 2012, 21 : 111 - 111
  • [29] Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?
    Vemulapalli, Sreekanth
    Tyson, Crystal C.
    Svetkey, Laura P.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (06) : 489 - 499
  • [30] Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal
    Spradley, Frank T.
    Smith, Jillian A.
    Alexander, Barbara T.
    Anderson, Christopher D.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2018, 315 (05): : E795 - E814